Bio Nebraska member, ProTransit Nanotherapy, will launch human clinical trials this summer with products that could help prevent and, in some cases, improve sunspots and neutralize free radicals, both precursors to skin cancer. Read more
An op-ed by Rob Owen, our executive director, was published in the Lincoln Journal Star about our state’s bioscience sector stepping up during the age of coronavirus. Read more
Adjuvance Technologies Inc., a member of Bio Nebraska, announced that they have been awarded supplemental contract funding from the National Institute of Allergy and Infectious Diseases (NIAID). Read more
In the plains of Nebraska, you’ll find AbrechtGFX, a company that tells the story of scientific innovation through 3D illustrations and animations by translating scientific and technical content into visuals that make information understood and messages memorable. Read more
Are you registered for the BIO International Convention yet? Join BIO for a digital format of their annual conference from June 8 through June 12. Read more
By Kevin Cole Omaha World-Herald staff writer.
UNO is offering scholarships to thank UNMC and Nebraska Medicine employees and their family members amid the COVID-19 pandemic. Read more
By Julie Anderson Omaha World-Herald staff writer.
The University of Nebraska Medical Center has signed an agreement with a New York-based testing company to provide large-scale antibody testing. Read more
By Kevin Warneke / Special for Streck Inc. in Omaha World-Herald.
It started with the dogged determination of a university professor with expertise in molecular diagnostics for antibiotic resistance.
Read more
Several Bio Nebraska members, with five having Nebraska locations, rank in the top 20 of Animal Pharm’s animal health industry rankings of 2019. Read more
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of …